Centessa Pharmaceuticals (CNTA) Earnings Date, Estimates & Call Transcripts $12.00 -1.57 (-11.60%) Closing price 05/6/2025 03:59 PM EasternExtended Trading$13.75 +1.75 (+14.62%) As of 04:26 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Centessa Pharmaceuticals Earnings Summary Upcoming Earnings DateMay. 12Before Market OpensEstimatedConsensus EPS (Mar. 24) -$0.38 Actual EPS (Mar. 24) -$0.34 Beat By $0.04 Centessa Pharmaceuticals announced Q4 2024 earnings on March 24, 2025, reporting an EPS of -$0.34, which topped the consensus estimate of -$0.38 by $0.04. With a trailing EPS of -$1.99, Centessa Pharmaceuticals' earnings are expected to grow next year, from ($1.60) to ($1.50) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Press Release (8-K) Annual Report (10-K)SEC FilingCNTA Upcoming EarningsCentessa Pharmaceuticals' Q1 2025 earnings is scheduled for Monday, May 12, 2025, with a conference call scheduled at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportPowered by Get Centessa Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Centessa Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCNTA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Centessa Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.38-$0.37-$0.38Q2 20252-$0.41-$0.38-$0.40Q3 20252-$0.44-$0.40-$0.42Q4 20252-$0.41-$0.40-$0.41 Centessa Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/12/2025(Estimated)-------3/24/2025Q4 2024-$0.38-$0.34+$0.04-$0.84--11/12/2024--$0.42-$0.37+$0.05-$0.37--8/13/2024--$0.38-$0.40 -$0.02-$0.40--5/13/2024Q1 2024-$0.41-$0.38+$0.03-$0.38--3/28/2024Q4 2023-$0.44-$0.38+$0.06-$0.38-$6.85M11/13/2023Q3 2023-$0.46-$0.40+$0.06-$0.40--8/14/2023Q2 2023-$0.43-$0.26+$0.17-$0.26--5/12/2023Q1 2023-$0.39-$0.53 -$0.14-$0.53-- Centessa Pharmaceuticals Earnings - Frequently Asked Questions When is Centessa Pharmaceuticals's earnings date? Centessa Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 12th, 2025 based off last year's report dates. Learn more on CNTA's earnings history. Did Centessa Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Centessa Pharmaceuticals (NASDAQ:CNTA) reported ($0.34) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.38) by $0.04. Learn more on analysts' earnings estimate vs. CNTA's actual earnings. How can I view Centessa Pharmaceuticals's earnings report? Centessa Pharmaceuticals's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Centessa Pharmaceuticals generate each year? Centessa Pharmaceuticals (NASDAQ:CNTA) has a recorded annual revenue of $6.85 million. How much profit does Centessa Pharmaceuticals generate each year? Centessa Pharmaceuticals (NASDAQ:CNTA) has a recorded net income of -$151.09 million. CNTA has generated -$1.99 earnings per share over the last four quarters. What is Centessa Pharmaceuticals's EPS forecast for next year? Centessa Pharmaceuticals's earnings are expected to grow from ($1.60) per share to ($1.50) per share in the next year. More Earnings Resources from MarketBeat Related Companies LNTH Earnings BBIO Earnings TGTX Earnings LEGN Earnings SRPT Earnings ADMA Earnings BPMC Earnings VRNA Earnings NUVL Earnings AXSM Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Palantir Stock Drops Despite Stellar Earnings: What's Next?Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?Is Reddit Stock a Buy, Sell, or Hold After Earnings Release?Warning or Opportunity After Super Micro Computer's EarningsAmazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousRocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2 This page (NASDAQ:CNTA) was last updated on 5/7/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centessa Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Centessa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CNTA Stock Free CNTA Stock Alerts